We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cell-Building Discovery Could Reduce Need for Some Animal Research

By LabMedica International staff writers
Posted on 23 Feb 2009
Biomedical engineers, using a three-dimensional (3D) Petri dish they invented, have successfully built complex-shaped microtissues by assembling small building blocks of living cell clusters. More...
This new development should help advance the field of tissue engineering and could reduce the need for some animal research.

The Brown University (Providence, RI, USA) team, led by Brown professor Dr. Jeffrey Morgan, successfully used clusters of cells to build microtissues of more complex shapes. Such a finding, detailed in the March 1, 2009, issue of Biotechnology and Bioengineering and posted at the end of January 2009 on the journal's Website, has enormous implications for basic cell biology, drug discovery and tissue research, according to Dr. Morgan.

Because the tissues Dr. Morgan's team created in the laboratory are more like natural tissue, they can be constructed to have complicated lace-like patterns similar to a vasculature, the arrangement of blood vessels in the body or in an organ. According to Dr. Morgan, that added complexity could ultimately reduce the need to use animals in specific kinds of research. "There is a need for...tissue models that more closely mimic natural tissue already inside the body in terms of function and architecture,” said Dr. Morgan, a Brown professor of medical science and engineering. "This shows we can control the size, shape, and position of cells within these 3D structures.”

But according to Dr. Morgan, this development also makes a significant contribution to the field of tissue engineering and regenerative medicine. "We think this is one step toward using building blocks to build complex-shaped tissues that might one day be transplanted,” he said.

The new finding builds on earlier research by Dr. Morgan and a team of Brown students, which appeared in September 2007 in the journal Tissue Engineering. The earlier study highlighted the invention of a 3D Petri dish about the size of a peanut-butter cup and made of agarose, a complex carbohydrate derived from seaweed with the consistency of Jell-O (a gelatin dessert). Dr. Morgan and students in his lab developed the dish, creating a product where cells do not adhere to the surface. Instead, the cells self-assemble naturally and form "microtissues.”

For the new study, Dr. Morgan and coworkers made 3D microtissues in one 3D Petri dish, harvested these living building blocks and then added them to more complex 3D molds shaped either like a honeycomb, with holes, or a donut with a hole in the middle. Those skin cells fused with liver cells in the more complex molds and formed even larger microstructures. Researchers found that the molds helped control the shape of the final microtissue. They also found that they could control the rate of fusion of the cells by aging them for a longer or shorter time before they were harvested. The longer the wait, Dr. Morgan discovered, the slower the process.

Related Links:

Brown University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.